Stock PRO PROMIMIC AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Promimic AB

Equities

PRO

SE0017487242

Biotechnology & Medical Research

Delayed Nasdaq Stockholm
Other stock markets
 12:30:00 29/05/2024 pm IST 		5-day change 1st Jan Change
33.3 SEK 0.00% Intraday chart for Promimic AB +11.00% +1.83%
22/05 Promimic AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
28/02 Promimic AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Business Summary

Promimic AB is a Sweden-based biomaterial company. The Company manufactures, markets and sells biomaterials for improved osseointegration (bone healing) to the companies in the markets for orthopedic and dental implants. The Company operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets.

Number of employees: 17

Sales per Business

SEK in Million2022Weight2023Weight Delta
Nano-coatings
100.0 %
16 100.0 % 37 100.0 % +128.63%

Sales per region

SEK in Million2022Weight2023Weight Delta
Sweden
100.0 %
16 100.0 % 37 100.0 % +128.63%

Managers

Managers TitleAgeSince
Magnus Larsson CEO
 Chief Executive Officer - 18/17/18
Per Gunnar Kjellin FOU
 Founder 52 01/04/01
Per Johan Martin Andersson FOU
 Founder 50 01/04/01
Annelie Skafte Persson DFI
 Director of Finance/CFO 59 01/21/01
Ulf Herman Brogren PRN
 Corporate Officer/Principal 51 -

Members of the board

Members of the board TitleAgeSince
Sven Krook BRD
 Director/Board Member 58 27/16/27
Tommy Karlsson BRD
 Director/Board Member 78 01/18/01
Per Gunnar Kjellin FOU
 Founder 52 01/04/01
Per Johan Martin Andersson FOU
 Founder 50 01/04/01
Inger Rydin BRD
 Director/Board Member 67 01/21/01
Jan Patrik Sjöstrand BRD
 Director/Board Member 51 01/17/01
Helena Maria Brisby BRD
 Director/Board Member 59 01/21/01
Johan Dighed BRD
 Director/Board Member 51 01/21/01
Pehr Abrahamsson BRD
 Director/Board Member 57 01/21/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,657,326 3,263,039 ( 17.49 %) 0 17.49 %

Shareholders

NameEquities%Valuation
K-Svets Venture AB
39.19 %
7,218,840 39.19 % 18 M kr
Karolinska Development AB (Private Equity)
14.31 %
2,636,420 14.31 % 7 M kr
Chalmers Ventures AB
6.723 %
1,238,510 6.723 % 3 M kr
Riepen LLC
5.623 %
1,035,836 5.623 % 3 M kr
Andra AP-fonden
5.201 %
958,090 5.201 % 2 M kr
Andersson & Kjellin AB
3.753 %
691,360 3.753 % 2 M kr
Swedbank Robur Fonder AB
3.387 %
624,000 3.387 % 2 M kr
Per Gunnar Kjellin
2.020 %
372,106 2.020 % 922 138 kr
NORDNET AB
2.020 %
372,086 2.020 % 922 089 kr
Marinvest Holding AB
1.696 %
312,500 1.696 % 774 425 kr

Company contact information

Promimic AB

AZ BioVentureHub, HB4

431 83, Mölndal

+46 31 16 08 60

http://www.promimic.com
address Promimic AB(PRO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PROMIMIC AB Stock Promimic AB
+1.83% 58.92M
MODERNA, INC. Stock Moderna, Inc.
+54.05% 58.71B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.02% 41.31B
LONZA GROUP AG Stock Lonza Group AG
+37.77% 39.2B
CELLTRION, INC. Stock Celltrion, Inc.
-10.22% 27.4B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.42% 26.55B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.60% 18.98B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+2.89% 12.51B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+22.40% 11.94B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.49% 12.08B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PRO Stock
  4. Company Promimic AB